Trulicity 0.75mg Pre-Filled Pen
Marketer
Eli Lilly and Company India Pvt Ltd
Salt Composition
Dulaglutide (0.75mg/0.5ml)
Overview Trulicity 0.75mg Pre-Filled Pen
For adults with type 2 diabetes, the injectable Trulicity 0.75mg pre-filled pen lowers blood sugar. This medication stimulates insulin production and reduces liver glucose output. Dosage of the 0.75mg pen is individualized, depending on your health and other diabetes treatments. Administer it at any time, with or without food, but consistently on the same day weekly for optimal results. Your healthcare provider will demonstrate proper injection technique. Always adhere to instructions; discontinuation requires consultation with your doctor to avoid potentially serious complications from elevated blood glucose. Combine Trulicity with a healthy diet and regular exercise for effective blood sugar management. Refrigerate the pen until use, avoiding freezing. Common side effects include nausea, diarrhea, stomach pain, and decreased appetite. Hypoglycemia (low blood sugar) is possible, particularly with concurrent blood sugar-lowering medications; learn to identify and manage this. Consult your physician before use if you have a history of liver or kidney disease, pancreatitis, or digestive issues. Disclose all medications to your doctor to avoid potential interactions. Pregnant or breastfeeding individuals should seek medical advice regarding Trulicity's suitability.
Primary Ingredients of Trulicity 0.75mg Pre-Filled Pen
No text provided to rephrase.
Uses of Trulicity 0.75mg Pre-Filled Pen
Managing type 2 diabetes
Major Benefits of Trulicity 0.75mg Pre-Filled Pen:
Your healthcare provider will instruct you on the proper administration of this medication.
Common Side effects of Trulicity 0.75mg Pre-Filled Pen:
- Nausea
- Diarrhea
- Vomiting
- Abdominal pain
- Loss of appetite
How to use Trulicity 0.75mg Pre-Filled Pen:
Your healthcare provider will instruct you on the proper administration of this medication.
How Trulicity 0.75mg Pre-Filled Pen works:
Trulicity 0.75mg pre-filled pen is an antidiabetic drug that enhances pancreatic insulin secretion, suppresses hyperglycemic hormones, decelerates gastric emptying, and diminishes appetite.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Trulicity 0.75mg Pre-Filled Pen is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using the Trulicity 0.75mg pre-filled pen during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Trulicity 0.75mg pre-filled pen use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Trulicity 0.75mg Pre-Filled Pen on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The 0.75mg Trulicity pre-filled pen is considered safe for individuals with kidney disease; no dosage alteration is necessary. Nevertheless, patients with impaired renal function experiencing significant gastrointestinal side effects should have their kidney function tracked. Exercise prudence when administering the 0.75mg Trulicity pre-filled pen to patients with end-stage renal disease (ESRD).
LiverSAFE IF PRESCRIBED
The use of the Trulicity 0.75mg pre-filled pen in patients with liver disease appears to present a low risk. Existing evidence indicates that a dosage modification may not be necessary for this patient population. However, physician consultation is advised.
What if you forget to take Trulicity 0.75mg Pre-Filled Pen :
Forgetting a Trulicity 0.75mg Pre-Filled Pen injection? Administer it immediately upon recollection, unless your next scheduled dose falls within 72 hours; in that case, omit the missed injection. Avoid injecting two doses of Trulicity 0.75mg Pre-Filled Pen within a three-day period.
Facts to Know About Trulicity 0.75mg Pre-Filled Pen
| Label | Value |
|---|---|
| Chemical Category | GLP-1 Receptor Agonist |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | GLP-1 Receptor Agonists: Insulin Stimulators |



